New Research In
Physical Sciences
Social Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
- Agricultural Sciences
- Anthropology
- Applied Biological Sciences
- Biochemistry
- Biophysics and Computational Biology
- Cell Biology
- Developmental Biology
- Ecology
- Environmental Sciences
- Evolution
- Genetics
- Immunology and Inflammation
- Medical Sciences
- Microbiology
- Neuroscience
- Pharmacology
- Physiology
- Plant Biology
- Population Biology
- Psychological and Cognitive Sciences
- Sustainability Science
- Systems Biology
FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice
Contributed by Thomas C. Südhof, June 1, 2016 (sent for review August 24, 2015; reviewed by Anton Maximov, Yi E. Sun, and Li-Huei Tsai)
Significance
Direct reprogramming of nonneuronal cells into induced neuronal (iN) cells has been of great interest for its potential applications in neurological disease modeling. Although this approach is well-established using cells from embryonic and neonatal animals, its applicability for cells from adult and aged animals has remained unexplored. This study demonstrates that iN cells can be efficiently generated from aging animals, but that age-dependent roadblocks which depend on the transcription factor FoxO3 affect the reprogramming efficiency and functional maturation of iN cell properties. Eliminating these roadblocks may be useful for modeling age-related neurological disorders using iN cells.
Abstract
We and others have shown that embryonic and neonatal fibroblasts can be directly converted into induced neuronal (iN) cells with mature functional properties. Reprogramming of fibroblasts from adult and aged mice, however, has not yet been explored in detail. The ability to generate fully functional iN cells from aged organisms will be particularly important for in vitro modeling of diseases of old age. Here, we demonstrate production of functional iN cells from fibroblasts that were derived from mice close to the end of their lifespan. iN cells from aged mice had apparently normal active and passive neuronal membrane properties and formed abundant synaptic connections. The reprogramming efficiency gradually decreased with fibroblasts derived from embryonic and neonatal mice, but remained similar for fibroblasts from postnatal mice of all ages. Strikingly, overexpression of a transcription factor, forkhead box O3 (FoxO3), which is implicated in aging, blocked iN cell conversion of embryonic fibroblasts, whereas knockout or knockdown of FoxO3 increased the reprogramming efficiency of adult-derived but not of embryonic fibroblasts and also enhanced functional maturation of resulting iN cells. Hence, FoxO3 has a central role in the neuronal reprogramming susceptibility of cells, and the importance of FoxO3 appears to change during development.
Recent advances in direct reprogramming have demonstrated the feasibility of converting fibroblasts and other terminally differentiated lineages into induced neuronal (iN) cells (1⇓⇓⇓⇓⇓⇓–8). iN cells display elaborate morphologies typical of neurons, express pan-neuronal markers, exhibit hallmarks of functional neurons in that they fire action potentials and form abundant synapses, and, thus, provide a great opportunity for studying the cellular phenotypes of disease-associated genetic mutations (9). To date, most studies used embryonic or early postnatal fibroblasts for reprogramming purposes, but for clinical applications, and in particular for modeling age-related neurodegenerative diseases, it would be preferable to generate iN cells from adult and aged animals.
Lineage conversion from aged cells is often challenging, probably due to epigenetic changes during aging. For example, aging has been shown to impair conversion of somatic cells into induced pluripotent stem cells (3, 10⇓–12). A recent elegant paper demonstrated successful conversion of fibroblasts from old individuals, but cellular properties were not compared between different age groups (13). In embryonic fibroblasts, overexpression of three transcription factors, Brn2, Ascl1, and Myt1l (BAM), efficiently generates iN cells with mature, functional properties within 2 wk (1). Genomic studies and chromatin characterization experiments of fibroblasts shortly after BAM factor expression revealed unique pioneer factor properties of Ascl1, which led to our observation that Ascl1 alone is sufficient to generate functional iN cells, albeit slower and with lower efficiency than when all three BAM transcription factors are used (14, 15). Recently, we observed that the longevity-associated forkhead transcription factor, FoxO3, shares common genomic targets with Ascl1 and, when overexpressed, significantly impairs iN cell reprogramming (16). FoxO3 functions downstream of the insulin/IGF signaling pathway and has also been shown to maintain adult neural precursor cell homeostasis (17⇓–19). Thus, FoxO3 might indirectly also affect neurogenesis.
Our aims for the present study were threefold: first, we wanted to assess whether it is possible to reprogram fibroblasts from aged mice into neurons; second, we wanted to elucidate whether aging affects the dynamics of neuronal conversion of fibroblasts; and finally, we wanted to investigate whether intrinsic, aging-associated factors, such as members of the FoxO family of transcription factors, influence iN cell formation in an age-dependent manner.
Results
Generation of Functional iN Cells from Fibroblasts of Old Mice.
We have shown that forced expression of a pool of three transcription factors, Brn2, Ascl1, and Myt1l, successfully converts mouse embryonic fibroblasts (MEFs) and early postnatal tail-tip fibroblasts (TTFs) into iN cells (1). To establish whether aging fibroblasts can also be converted into iN cells, we derived cultures from tails of 17- to 20-month-old Tau:EGFP mice that express EGFP from the endogenous, neuron-specific Tau locus (20). The tail-tip fibroblasts were then lentivirally transduced with BAM transcription factors. Three weeks later, we detected bright EGFP+ cells with clear neuronal morphologies and expression of the pan-neuronal marker Tuj1 (Fig. 1A). Electrophysiological characterization demonstrated that TTF-derived iN (TTF iN) cells generated from aged animals were functional in terms of firing action potentials (APs) and exhibiting voltage-gated sodium and potassium currents (Fig. 1B). Thus, the BAM reprogramming factors are capable of converting fibroblasts from aged donors into functional neurons.
Developmental Stage but Not Adult Aging Impairs iN Cell Reprogramming.
To more systematically evaluate the impact of aging on reprogramming efficiency of fibroblasts, we derived TTFs from mice of different ages including embryonic (MEF), postnatal (4 d), young adult (3 mo), middle aged (10 and 15 mo), and aged (25 mo) mice. Following BAM transduction, fibroblasts from all ages were able to form Tuj1 and Map2 immunopositive iN cells with neuronal morphology (Fig. 1C). However, the reprogramming efficiency and dynamics of iN cell generation were reduced dramatically in postnatal cells compared with MEFs and showed a further slight decrease in subsequent age-groups tested (Fig. 1 C and D and Fig. S1).
To test the effect of aging on functional maturation of iN cells, we performed patch-clamp recordings from postnatal, juvenile, and aging adult TTF iN cells and directly compared their intrinsic membrane properties with those of MEF iN cells. We noticed that TTF iN cells generated from aging mice displayed a consistent increase in the failure rate for AP firing (Fig. 2A). Moreover, quantification of intrinsic membrane properties indicated a less mature state of iN cells from aged mice, such as a less polarized resting membrane potential (Vrest), a higher membrane resistance (Rm), and a lower capacitance (Cm) (Fig. 2B). Finally, when cocultured with mouse primary hippocampal neurons (Fig. S2), TTF iN cells derived from juvenile and aged mice showed a significant decrease in both the frequency and amplitude of spontaneous AMPA receptor- (AMPAR-) mediated miniature excitatory postsynaptic currents (mEPSCs) compared to MEF iN cells (Fig. 2C). When excitatory postsynaptic currents (EPSCs) were evoked by APs of surrounding cells with an extracellular stimulation electrode, thus activating the majority of synapses projecting onto the recorded cell, we observed a steep decrease in AMPAR-mediated synaptic transmission between MEF-iN and neonatal TTF-iN cells and a further substantial decrease between neonatal TTF-iN and adult TTF-iN cells (Fig. 2D). As with other parameters, there was no significant difference between TTF-iN cells from 3- or 25-mo-old mice (Fig. 2D).
Thus, the conversion effciency massively decreases when fibroblasts are derived from postnatal tail tips instead of embryos, but decreases surprisingly little when fibroblasts are derived from aging mice instead of neonatal mice (Figs. 1D and 2 B–D and Fig. S3). The small differences in iN cell reprogramming efficiency between young and aged adult fibroblasts are in accordance with published findings on neuronal differentiation from neural stem/progenitor cells (NSPCs). Similar to what we find for reprogramming, embryonic NSPCs differentiated more efficiently into neurons than adult NSPCs, but no difference was detected between young and aged adult NSPCs (21).
Several Aging-Associated Cellular Features Correlate with Reduced Reprogrammability.
We next monitored a number of qualitative aging-associated parameters. In a similar context, induced pluripotent stem (iPS) cell reprogramming has been shown to be strongly influenced by cell proliferation and senescence (10, 22, 23). We therefore wondered whether these two factors also affect the quality of the donor fibroblasts derived from mice of different ages, which may influence their susceptibility to iN cell reprogramming. As expected, a 4-h pulse staining with 5-ethynyl-2′-deoxyuridine (EdU) revealed a decreased cell proliferation rate in fibroblasts as a function of the age of the donor mice (Fig. 3 A and B). Staining with senescence-associated β-galactosidase (SA-β-Gal) indicated that aging fibroblasts undergo a parallel significant increase in cellular senescence (Fig. 3 A and B). Accordingly, we observed a strong increase in mRNA expression levels of the senescence-associated genes p16 and p19 in aged donor fibroblasts (Fig. 3B). Finally, quantification of plating and infection efficiency demonstrated a significant decrease of both parameters in TTFs compared with MEFs (Fig. 3 C and D).
In summary, these findings suggest that the combination of lower proliferation, plating, and infection rates, and increased senescence, is responsible for the decreased reprogramming efficiency of TTFs derived from aging mice compared with MEFs.
Loss of FoxO3 Improves Neuronal Conversion of Fibroblasts from Aging Mice.
Given the lower efficiency of BAM-induced iN cell conversion of adult fibroblasts, we sought to find means to improve reprogramming. Our previous studies indicated that of the three BAM transcription factors originally identified, Ascl1 is the main driver of iN cell reprogramming (1, 14, 15). Of note, Ascl1 alone is sufficient to induce iN cell reprogramming in fibroblasts (14, 15). We had observed earlier that FoxO3, a longevity-associated transcription factor, shares genomic targets with Ascl1 and inhibits some of the Ascl1 target genes (16). Indeed, we confirmed that overexpression of FoxO3 impaired BAM-mediated neurogenesis from MEFs (Fig. 4A). In light of these findings, we wondered whether deletion of FoxO3 could improve neuronal conversion of TTFs derived from aging mice.
To this end, we first evaluated the expression levels of FoxO transcription factor genes (FoxO1, FoxO3, FoxO4, and FoxO6) in fibroblasts. Our quantitative RT-PCR (qRT-PCR) assay revealed that all family members were robustly expressed in MEFs and in TTFs derived from postnatal and adult mice (Fig. S4), as reported for skeletal muscle (24). We next derived MEFs, and adult TTFs from WT and FoxO3−/− littermate mice of various age groups. Unexpectedly, germ-line loss of FoxO3 also reduced FoxO6 expression without affecting FoxO1 or FoxO4 mRNA levels (Fig. S4), indicating a genetic interaction between the FoxO3 and FoxO6 genes. Upon BAM factor induction, both WT and FoxO3−/− TTFs were reprogrammed into iN cells for all age groups tested. For TTFs derived from young and aged mice, but not for MEFs, we detected a significant increase in the number of Map2+ iN cells transdifferentiated from FoxO3−/− TTFs compared with WT TTFs (Fig. 4 B and C). Surprisingly, this increase in efficiency was not due to differences in infectability, proliferation, or senescence rates between WT and FoxO3−/− TTFs (Fig. S5). In addition, shRNA-mediated knockdown of FoxO3 in 3M TTFs also significantly increased the reprogramming efficiency of iN cells (Fig. 4D). Thus, the increase in reprogramming efficiency appears to be a direct consequence of reduced FoxO3 transcriptional activity in adult fibroblasts and cannot be explained by secondary changes in adult cells devoid of FoxO3 since the beginning of embryonic development.
Finally, to test whether loss of FoxO3 also has an effect on the functional properties of iN cells, we performed current-clamp recordings from iN cells derived from WT and FoxO3−/− TTFs. A larger fraction of FoxO3−/− iN cells generated from TTFs of different age groups fired APs than of WT iN cells; this difference was absent in a comparison between FoxO3−/− and WT iN cells generated from MEFs (Fig. 4 E and F). Concordantly, iN cells from adult FoxO3−/− TTFs but not from MEFs showed a lower Vrest and an increased AP height compared with corresponding WT conditions (Fig. 4G). Thus, loss of FoxO3 improves iN cell reprogramming efficiency and functional maturation of iN cells selectively from adult but not embryonic fibroblasts.
Discussion
Lineage conversion of cells from adult animals in general has proven difficult. For example, the iPS cell reprogramming efficiency and kinetics were significantly reduced for cells from older compared with younger animals (3, 10⇓–12). Furthermore, senescence and proliferative capacity have also been shown to influence iPS cell reprogramming (10, 22, 23). In agreement with these observations, our findings on iN cell reprogramming also suggest an inverse correlation between development and cellular reprogrammability. Remarkably, however, we did not detect any significant difference in the efficiency of reprogramming or function of iN cells from fibroblasts derived from young or aging mice. This finding is in accordance with the finding that the neuronal differentiation capacity of endogenous neural stem cells did not change from adult to aged animals, and that once mature neurons had formed, there were no detectable differences in their function (21).
The cell-biological mechanisms that cause aging remain largely a mystery. Presumably, a complex combination of many different changes is responsible for the variety of phenotypical and functional alterations induced by aging. Therefore, we were surprised to note that a simple genetic manipulation significantly increased iN cell reprogramming susceptibility in fibroblasts derived from adult but not embryonic mice. Specifically, germ-line loss of the longevity-associated transcription factor FoxO3 increased both conversion efficiency and function of iN cells from adult and aged fibroblasts. This effect was not due to differences in infection rate, proliferation, or level of senescence of the donor fibroblasts. Rather, our knockdown experiments suggest that this effect may involve a direct molecular mechanism of FoxO3 to inhibit the induction of the neuronal program induced by the reprogramming factors. This hypothesis is supported by our previous findings that FoxO3 shares genomic targets with the iN cell reprogramming transcription factor Ascl1 and inhibits its transcription and neurogenic effect when overexpressed (16). We thus speculate that by removing FoxO3 from cells, Ascl1 can exert its full neurogenic potential and, thus, more efficiently reprogram fibroblasts.
Remarkably, the effect of FoxO3 on iN cell reprogramming was not observed in embryonic fibroblasts despite robust FoxO3 expression. Moreover, the reduction of FoxO6 levels in FoxO3−/− cells was seen in both MEFs and adult fibroblasts. Thus, the age-specific phenotype of FoxO3 cannot simply be explained by loss or compensation of other FoxO family members. These results suggest that FoxO3 direct transcriptional function heavily depends on the age-related cellular context and is fundamentally different in cultured MEFs than adult TTFs under otherwise identical growth conditions. It was described that FoxO3 regulates neural stem cell homeostasis only in adult but not embryonic or neonatal animals, a similar, age-dependent function of FoxO3 (19).
Here, we demonstrate the proof of principle that cells from old animals can still be converted to neurons without decline in efficiency with increased adult age. Because the most common diseases of the brain affect adult and elderly patients, this result is of relevance for potential applications of this technology in both disease modeling and regenerative medicine.
Experimental Procedures
Animals.
All experimental procedures were approved by Stanford’s administrative panel on laboratory animal care and were in accordance with national guidelines. Animals used for this project include WT C57BL/6 mice (Charles River or NIA colony) (Figs. 1 C and D, 2, 3, and 4 A and D, and Figs. S1–S3), and FoxO3 WT/KO mice (from Ronald A. DePinho, Dana–Farber Cancer Center, Boston, MA) (Figs. 1B and 4 B, C, and E–G and Figs. S4 and S5). FoxO3 KO mice were genotyped by PCR as described previously (25) before the start of all experiments. In addition, loss of FoxO3 expression in TTFs was verified by qRT-PCR (Fig. S4B). For Fig. 1A, homozygous male Tau-EGFP mice (Jackson Laboratory) were bred with WT C57BL/6 mice and heterozygous offspring were used for experiments.
Cell Culture.
Embryonic day 13.5 MEFs and postnatal fibroblasts were derived as described (1). Adult and aging fibroblasts were derived from mouse tails (TTF) by cutting the tissue into small pieces, followed by trypsin digestion, brief air drying on culture plates to enhance attachment, adding MEF media [DMEM high glucose, 10% (vol/vol) calf serum, 2 mM l-glutamine,1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 50 U Penicillin-Streptomycin (Life Technologies) and β-mercaptoethanol (Sigma)] and subsequent isolation of fibroblast outgrowths. Fibroblasts from all ages were further expanded for 1–3 passages before reprogramming experiments. Primary hippocampal cultures were prepared from CD1 mice (Charles River) postnatal day 0–1.
Generation of iN Cells.
For reprogramming experiments, fibroblasts were plated on Poly-orinitine/Laminin or Matrigel (BD Biosciences) coated dishes. Lentiviruses encoding the cDNAs for Ascl1-T2A-Brn2, Myt1l, and FoxO3 (driven by doxycycline-inducible Tet-on promoter) together with rtTA (under Ubiquitin promoter) were used to coinfect fibroblasts in MEF media in the presence of polybrene (8 mg/mL; Sigma). For knockdown experiments, cells were coinfected with pSico vectors carrying the shRNA of a scrambled control (ATCTCGCTTGGGCGAGAGT) or a FoxO3 (AAGCAGGCCTCATCTCAAA) sequence. The day after infection, MEF media was replaced with N3B27 media (DMEM/F12, N2, B27, 5 mg/mL insulin, doxycycline) with doxycycline (2 mg/mL; Sigma). The iN cell cultures were subsequently maintained with half media exchanges every 3 d. For cocultures with primary neurons, iN cells where enriched by infecting fibroblast with Ascl1-T2A-Brn2-ires-puror, Myt1l, rtTA, and eGFP. After 24 h of induction, cells were selected for 48 h, and after an additional 4 d, iN cells were dissociated and replated on 2- to 3-d in vitro mouse hippocampal cultures.
Electrophysiology.
Electrophysiology experiments (current-clamp for AP generation, and voltage-clamp for synaptic recording) on TTF iN cells were performed essentially as described (9). In brief, EGFP+ iN cells, only with elaborate neuronal morphology, were patched in whole-cell configuration by using internal solution containing: (for voltage-clamp) 135 mM CsCl2, 10 mM Hepes, 1 mM EGTA, 1 mM Na-GTP, and 1 mM QX-314 (pH 7.4, 310 mOsm); or (for current-clamp) 130 mM KMeSO3, 10 mM NaCl, 10 mM Hepes, 2 mM MgCl2, 0.5 mM EGTA, 0.16 mM CaCl2, 4 mM Na2ATP, 0.4 mM NaGTP, and 14 mM Tris-creatine phosphate (pH 7.3, 310 mOsm). Extracellular solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM Hepes-NaOH pH 7.4. Current-clamp recordings for AP generation were performed at approximately −60 mV, with a small holding current to adjust membrane potential accordingly. Voltage-clamp recordings for synaptic responses were at a holding potential of −70 mV. AMPAR-mediated synaptic responses were recorded in presence of picrotoxin (GABAAR blocker, 50 µM; Tocris). AMPAR-evoked EPSCs were isolated by using an extracellular stimulation electrode as described previously (26).
Immunocytochemistry.
Cells were fixed with 4% paraformaldehyde, washed with PBS, incubated in T-PBS (PBS + 0.025% Triton X-100 + 5% serum) for 1 h at room temperature, then with desired primary antibodies at 4 °C overnight. Following washes, secondary antibodies were applied in T-PBS for 2 h at room temperature and finally washed with PBS. Primary antibodies used were as follows: mouse-anti-MAP2 (1:500, Sigma), rabbit anti-bIII Tubulin (Tuj1, 1:1000; Covance). Secondary antibodies used were donkey anti-mouse Alexa Fluor 555 and donkey-anti-rabbit Alexa Fluor 488 (1:1000; Life Technologies). For EdU staining, cells were pulsed with 10 mM EdU for 4 h and visualized by using ClickIT EdU kit (Life Technologies) according to manufacturer guidelines. SA-β-Gal staining was performed by using the senescencent cell staining kit (Sigma) according to the manufacturer’s guidelines. Nuclear counterstaining was performed with DAPI.
Cell Quantification and Neurite Length Measurements.
The conversion efficiencies for TTF iN cells from different age groups and genotypes were determined by counting total number of Tuj1+ and Map2+ cells with clear neuronal morphology in 20 random 20× field of views and presented as percentages of total plated cells. EdU+ and SA-β-Gal+ cells were counted in 10 random 40× field of views and indicated as average percentage of total DAPI-stained nucleus. Neurite length measurements were performed on randomly selected 10× Tuj1+ iN cell images by using the ImageJ software (NIH) with NeuronJ plug-in.
qRT-PCR.
Total RNA was isolated by using RNAeasy (Qiagen) with DNase treatment, reverse transcribed by using SuperScript II (Life Technologies) with oligo dT and qPCR performed with the 7900HT Real Time PCR system using SYBR green master mix (Applied Biosystems) and the following primers (for Fig. 3B and Fig. S5B):
GAPDH-Fwd: 5′tgtgtccgtcgttggatctga3′,
GAPDH-Rev: 5′ttgctgttgaagtcgcaggag3′,
p16-Fwd: 5′CGAACTCTTTCGGTCGTACCC3′,
p16-Rev: 5′CGAATCTGCACCGTAGTTGAGC3′,
p19-Fwd: 5′GTTCTTGGTCACTGTGAGGATTCAG3′, and
p19-Rev: 5′CCATCATCATCACCTGGTCCAG3′.
Additional primer information for FoxO3 KO validation and testing its subsequent effect on other FoxO family members is provided in Fig. S4.
Statistical Analyses.
All average bar-graph data are presented as means ± SEM. Statistical comparisons were made by using ANOVA with Bonferroni post hoc test (*P < 0.05, **P < 0.01, and ***P < 0.005) or two-tailed, unpaired Student t test (except for Fig. 4F, where a paired t test was performed), as individually mentioned in the figure legends.
Acknowledgments
We thank Ronald DePinho for the FoxO3 knockout mice, the members of the A.B. laboratory for sharing aged mice, and members of the M.W. laboratory for reagents and helpful discussions. This study was supported by NIH Grants AG010770-18A1 (to M.W., T.C.S., and S.B.P.) and R01MH092931 (to M.W. and T.C.S.); Swedish Research Council and Swedish Society for Medical Research Postdoctoral fellowships (to H.A.); and Stanford Institute for Chemical Biology Postdoctoral Grant ChEM-H112878 (to S.C.). T.C.S. is a Howard Hughes Medical Institute Investigator, and M.W. is a New York Stem Cell Foundation-Robertson Investigator and a Tashia and John Morgridge Faculty Scholar, Child Health Research Institute at Stanford.
Footnotes
↵1H.A. and S.C. contributed equally to this work.
↵2Present address: Department of Clinical Sciences, Lund Stem Cell Center, University Hospital BMC B10, SE-221 84 Lund, Sweden.
↵3Present address: Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02903.
- ↵4To whom correspondence may be addressed. Email: tcs1{at}stanford.edu or wernig{at}stanford.edu.
Author contributions: H.A., S.C., S.B.P., A.B., T.C.S., and M.W. designed research; H.A., S.C., A.E.W., I.Y., and J.K. performed research; A.B. contributed new reagents/analytic tools; H.A., S.C., A.E.W., J.K., T.C.S., and M.W. analyzed data; and H.A., S.C., and M.W. wrote the paper.
Reviewers: A.M., The Scripps Research Institute; Y.E.S., University of California, Los Angeles; and L.-H.T., Massachusetts Institute of Technology.
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1607079113/-/DCSupplemental.
References
- ↵
- ↵
- ↵.
- Cheng Z, et al.
- ↵
- ↵
- ↵
- ↵
- ↵.
- Pfisterer U, et al.
- ↵.
- Chanda S,
- Marro S,
- Wernig M,
- Südhof TC
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵.
- Ahlenius H,
- Visan V,
- Kokaia M,
- Lindvall O,
- Kokaia Z
- ↵.
- Banito A, et al.
- ↵
- ↵
- ↵.
- Castrillon DH,
- Miao L,
- Kollipara R,
- Horner JW,
- DePinho RA
- ↵
Citation Manager Formats
More Articles of This Classification
Biological Sciences
Related Content
- No related articles found.